USP Pharmaceutical Analytical Impurities

(2-(Pyridin-2-yl)ethanol)

(1-(6-Methoxyquinolin-4-yl)-3-[(3R,4R)-3-vinylpiperidin-4-yl]propan-1-one)

((2E,4E)-4-(4,4-Dimethylpent-2-ynylidene)-N1,N5-dimethyl-N1,N5-bis(naphthalen-1-ylmethyl)pent-2-ene-1,5-diamine dihydrochloride)

(Estra-1,3,5(10)-trien-3,17beta-diyl di(cyclopentanepropanoate))

(Ethyl(E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate)

(5-Chloro-2-pyridinamine)

(1,3-Dihydro-2H-benzimidazol-2-one)

(1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine)

(1-[3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl-4-methylpiperazineN4-oxide)

((3R,4R,5S)-4-Amino-5-acetylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester)

(1-(3-Methoxyphenyl)-2-(dimethylaminomethyl) cyclohex-6-ene hydrochloride)

(4-Acetylamino-3-hydroxybenzoic acid ethyl ester)

(N,N-Dimethyl-2-[1-phenyl-1-(pyridin-2-yl)ethoxy]ethan-1-amine oxide)

(alpha-Fluoronaphthalene)

(2-[(RS)-[4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole)

(10,11-dioxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)

(Dibenzo[b,e]pyridine)

(10-Methoxy-5H-dibenz[b,f]azepine-5-carboxamide)

(2-Methylpropan-2-amine (2S,3aS,7aS)-1-((2S)-2-(3-cyclohexyl-2,4-dioxo-5-propylimidazolidin-1-yl)propanoyl)octahydro-1H-indole-2-carboxylate)

(3-Isobutylpentanedioic acid)

(2-(5-{[4-({2-[Methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methyl}-2,4-dioxo-1,3-thiazolidin-3-yl)butanedioic acid)

(3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanamide;3-[4-({2-[Methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]propanamide)

(10 mg

((1RS,4RS)-4-(2,3-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride)